×
LifeMD Receivables 2011-2025 | LFMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
LifeMD receivables from 2011 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
LifeMD Receivables 2011-2025 | LFMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
LifeMD receivables from 2011 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$141.5B
CVS Health (CVS)
$81.4B
Elevance Health (ELV)
$76.8B
Cencora (COR)
$57.6B
DiDi Global (DIDIY)
$25.2B
Natera (NTRA)
$21.6B
Labcorp Holdings (LH)
$20.9B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$13.3B
CochLear (CHEOY)
$13B
Solventum (SOLV)
$12.8B
ICON (ICLR)
$12.1B
Revvity (RVTY)
$11.6B
Viatris (VTRS)
$10.7B
Medpace Holdings (MEDP)
$9.2B
Avantor (AVTR)
$9B
Sonic Healthcare (SKHHY)
$8.8B
HealthEquity (HQY)
$8.4B
Charles River Laboratories (CRL)
$7.8B
Caris Life Sciences,�Inc (CAI)
$7.1B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.8B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.3B
Surgery Partners (SGRY)
$2.9B
Alignment Healthcare (ALHC)
$2.7B
Concentras Parent (CON)
$2.6B
Organon (OGN)
$2.6B
GeneDx Holdings (WGS)
$2.4B
Ardent Health (ARDT)
$2.1B